ADHD medication study for young children
Treatments studied
Part of Mental health clinical trials.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 5 years old.
- They must have a confirmed diagnosis of moderate or severe ADHD by a doctor.
- They cannot have taken Methylphenidate or Guanfacine before.
- They should not have any medical conditions that make these medications unsafe, like serious heart problems or glaucoma.
- Your child's primary language must be English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
This trial tests a new medication, EB-1020, over a longer period in children with ADHD. It aims to see if the drug continues to be safe and effective beyond the initial 6-week treatment. Some participants may have already been in a previous EB-1020 study, while others are new.
This study looks at how your genes affect your response to Methylphenidate (a common ADHD medication, excluding the quick-release forms). If you live in Western Canada and are starting this treatment, your participation could help doctors personalize ADHD care in the future.
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
This trial tests if a medication called methylphenidate can help children with sickle cell disease who have trouble with attention, focus, or executive function. It aims to see if it can improve daily life and school performance.
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Hear when a new Attention-Deficit/Hyperactivity Disorder (ADHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.